FDA Adverse Event Malfunction Summary report: N

OMNIPOD INSULIN PUMP

MDR report key: 4232325 · Received October 22, 2014

Report

Report Number
3004464228-2014-01586
Event Type
Malfunction
Date Received
October 22, 2014
Date of Event
September 25, 2014
Report Date
September 25, 2014
Manufacturer
INSULET CORPORATION
Product Code
LZG
PMA / PMN Number
K122953
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE PRODUCT WAS NOT RETURNED FOR EVALUATION. THE USER REPORTED THAT HE WAS UNABLE TO VIEW IF THE CANNULA WAS PROPERLY INSERTED BUT WAS ABLE TO FEEL INSULIN ON HIS SKIN AT THE INFUSION SITE. THIS CONDITION COULD INTERRUPT INSULIN DELIVERY AND CONTRIBUTE TO HYPERGLYCEMIA. QUALIFICATION RECORDS WERE REVIEWED AND THE PRODUCT LOT MET ALL ACCEPTANCE CRITERIA.

Description of Event or Problem · 1

THE CUSTOMER REPORTED HIS BLOOD GLUCOSE REACHED 310 MG/DL LESS THAN 4 HOURS AFTER THE POD WAS ACTIVATED. HE WAS NOT ABLE TO SEE IF THE CANNULA WAS PROPERLY INSERTED OR NOT BUT DURING A BOLUS DELIVERY HE NOTICED THAT THE INSULIN WAS DELIVERING OUTSIDE OF HIS SKIN.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
670724 OMNIPOD INSULIN PUMP PUMP, INFUSION, INSULIN LZG INSULET CORPORATION 1400 L41174

Patients

Seq Age Sex Outcome Treatment
1 33 YR